Schmidt Denis, Gunera Jakub, Baker Jillian G, Kolb Peter
Department of Pharmaceutical Chemistry, Philipps-University Marburg, Marbacher Weg 6, 35032 Marburg, Germany.
Institute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.
ACS Med Chem Lett. 2017 Mar 27;8(5):481-485. doi: 10.1021/acsmedchemlett.6b00363. eCollection 2017 May 11.
The β-adrenergic receptor (βAR) is a G protein-coupled receptor (GPCR) and a well-explored target. Here, we report the discovery of 13 ligands, ten of which are novel, of this particular GPCR. They have been identified by similarity- and substructure-based searches using multiple ligands, which were described in an earlier study, as starting points. Of note, two of the molecules used as queries here distinguish themselves from other βAR antagonists by their unique scaffold. The molecules described in this work allow us to explore the ligand space around the previously reported molecules in greater detail, leading to insights into their structure-activity relationship. We also report experimental binding and selectivity data and putative binding modes for the novel molecules.
β-肾上腺素能受体(βAR)是一种G蛋白偶联受体(GPCR),也是一个经过充分研究的靶点。在此,我们报告了针对这一特定GPCR发现的13种配体,其中10种是新发现的。它们是通过以先前一项研究中描述的多种配体为起点,基于相似性和亚结构的搜索鉴定出来的。值得注意的是,这里用作查询的两个分子因其独特的骨架结构而有别于其他βAR拮抗剂。这项工作中描述的分子使我们能够更详细地探索先前报道分子周围的配体空间,从而深入了解它们的构效关系。我们还报告了新分子的实验结合和选择性数据以及推定的结合模式。